Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 6/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.37 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
| ▸ | F7 | P08709 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | F3 | P13726 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL396029 | 1.00 | GPR84 (0.42) | GPR84CFTRCSNK2A1MEN1POLB | |
| SCHEMBL8957480 | 0.84 | GPR84 (0.48) | GPR84CFTRCSNK2A1MEN1POLB | |
| SCHEMBL395515 | 0.81 | GPR84 (0.47) | GPR84CSNK2A1GFERAHRCYP2A6 | |
| SCHEMBL5495155 | 0.81 | GPR84 (0.47) | GPR84CSNK2A1GFERAHRCYP2A6 | |
| SCHEMBL21232469 | 0.80 | GPR84 (0.41) | GPR84CSNK2A1MEN1POLBMAPK1 | |
| SCHEMBL13285075 | 0.79 | GPR84 (0.44) | GPR84CFTRCSNK2A1MEN1POLB | |
| SCHEMBL8529327 | 0.78 | CSNK2A1 (0.55) | GPR84CFTRCSNK2A1MEN1POLB | |
| SCHEMBL26824096 | 0.78 | GPR84 (0.62) | GPR84CFTRCSNK2A1MEN1POLB | |
| SCHEMBL30741638 | 0.78 | CFTR (0.47) | GPR84CFTRCSNK2A1MEN1POLB | |
| SCHEMBL3131647 | 0.78 | GPR84 (0.54) | GPR84CSNK2A1MEN1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118818993-B | Zinc leaching multi-working-condition control method and system based on regression DeepRED rule extraction | 中南大学 | 2024-12-27 | — | — | CN | claimed |
| CN-118818993-A | Zinc leaching multi-working-condition control method and system based on regression DeepRED rule extraction | 中南大学 | 2024-10-22 | — | — | CN | claimed |
| US-20260146102-A1 | METHODS FOR MODULATING REGULATORY T CELLS | UNIVERSITE DE LAUSANNE (CH) | 2026-05-28 | — | — | US | disclosed |
| CN-122081496-A | Combined pharmaceutical composition for tumor treatment, application thereof and application of mitochondrial biosynthesis genes as biomarkers in tumor treatment | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122090446-A | Skeletal muscle organoid function analysis system and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-12630610-B2 | Binding molecules specific for HBV envelope protein | IMMUNOCORE LIMITED (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4734993-A2 | METHODS FOR SENSITIZING DRUG-RESISTANT CANCER CELLS | Dana-Farber Cancer Institute, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12607637-B2 | Super-resolution morphology-correlated detection of labile zinc | UNIVERSITY OF CINCINNATI (US) | 2026-04-21 | — | — | US | disclosed |
| EP-3849666-B1 | METHODS FOR MODULATING REGULATORY T CELLS AND INHIBITING TUMOR GROWTH | UNIV LAUSANNE (CH) | 2026-04-15 | — | — | EP | disclosed |
| US-20260060999-A1 | REINFORCEMENT OF MUCUS BARRIER PROPERTIES | Cirqle Biomedical Contraception Ivs (DK) | 2026-03-05 | — | — | US | disclosed |
| US-12544393-B2 | Apoptosis-mimicking structures for inducing tissue regeneration | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2026-02-10 | — | — | US | disclosed |
| US-11285174-B2 | Macrophage-based therapy for use in the treatment of liver injury | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2022-03-29 | — | — | US | disclosed |
| WO-2022055134-A1 | INJECTION COMPOSITION CONTAINING ISOLATED MITOCHONDRIA, AND USE THEREOF | 주식회사 파이안바이오테크놀로지 | 2022-03-17 | — | — | WO | disclosed |
| US-20220076393-A1 | SYSTEMS AND METHODS FOR IMAGE PROCESSING | GUANGZHOU COMPUTATIONAL SUPER-RESOLUTION BIOTECH CO., LTD. (CN) | 2022-03-10 | — | — | US | disclosed |
| WO-2022040319-A2 | METHODS AND COMPOSITIONS FOR INHIBITING VIRAL INFECTION | NEW YORK GENOME CENTER, INC. (US) | 2022-02-24 | — | — | WO | disclosed |
| US-20220049010-A1 | METHODS FOR MODULATING REGULATORY T CELLS AND INHIBITING TUMOR GROWTH | UNIV LAUSANNE (CH) | 2022-02-17 | — | — | US | disclosed |
| WO-2022031011-A1 | KINETICALLY ACTING ADJUVANT ENSEMBLE | 성균관대학교산학협력단 | 2022-02-10 | — | — | WO | disclosed |
| WO-2022031857-A2 | DEGRADABLE HOLLOW SHELL PARTICLES FOR HIGH-THROUGHPUT SCREENING AND SORTING OF CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-10 | — | — | WO | disclosed |
| WO-2022023380-A2 | ASSAY | KING'S COLLEGE LONDON (GB) | 2022-02-03 | — | — | WO | disclosed |
| EP-3942518-A1 | SYSTEMS AND METHODS FOR IMAGE PROCESSING | Guangzhou Computational Super-resolution Biotech Co., Ltd. (CN) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630610-B2 | Binding molecules specific for HBV envelope protein | CD74, HLA-DRB1, MICA | GPR84 1358/4885CFTR 2213/4885CSNK2A1 4249/4885 |
| US-12607637-B2 | Super-resolution morphology-correlated detection of labile zinc | SARAF, TFEB, CHERP | GPR84 4310/4885CFTR 2292/4885CSNK2A1 1892/4885 |
| US-20260060999-A1 | REINFORCEMENT OF MUCUS BARRIER PROPERTIES | MUC1, F12, EPCAM | GPR84 1157/4885CFTR 22/4885CSNK2A1 3816/4885 |
| US-20260146102-A1 | METHODS FOR MODULATING REGULATORY T CELLS | ICOS, PPARD, CD4 | GPR84 568/4885CFTR 183/4885CSNK2A1 4501/4885 |
| US-12544393-B2 | Apoptosis-mimicking structures for inducing tissue regeneration | BAX, BCL2, BAD | GPR84 943/4885CFTR 2145/4885CSNK2A1 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.